Cited by 783Blood Pressure and Hypertension StudiesSodium Intake and HealthCardiovascular Health and Disease Prevention

The DOI matches its Crossref record, with a small difference in title or year; 32 of the 33 references it cites were found in a registry or an index.

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis

Open access

Bundy, Joshua D., Li, Changwei, Stuchlik, Patrick, Bu, Xiaoqing, Kelly, Tanika N., Mills, Katherine T., He, Hua, Chen, Jing, Whelton, Paul K., He, Jiang·2017·JAMA Cardiology

DOI 10.1001/jamacardio.2017.1421PMC PMC5710614

Open this paper in CoChat — free account Open PDF

Abstract

Importance: Clinical trials have documented that lowering blood pressure reduces cardiovascular disease and premature deaths. However, the optimal target for reduction of systolic blood pressure (SBP) is uncertain. Objective: To assess the association of mean achieved SBP levels with the risk of cardiovascular disease and all-cause mortality in adults with hypertension treated with antihypertensive therapy. Data Sources: MEDLINE and EMBASE were searched from inception to December 15, 2015, supplemented by manual searches of the bibliographies of retrieved articles. Study Selection: Studies included were clinical trials with random allocation to an antihypertensive medication, control, or treatment target. Studies had to have reported a difference in mean achieved SBP of 5 mm Hg or more between comparison groups. Data Extraction and Synthesis: Data were extracted from each study independently and in duplicate by at least 2 investigators according to a standardized protocol. Network meta-analysis was used to obtain pooled randomized results comparing the association of each 5-mm Hg SBP category with clinical outcomes after adjusting for baseline risk. Main Outcomes and Measures: Cardiovascular disease and all-cause mortality. Results: Forty-two trials, including 144 220 patients, met the eligibility criteria. In general, there were linear associations between mean achieved SBP and risk of cardiovascular disease and mortality, with the lowest risk at 120 to 124 mm Hg. Randomized groups with a mean achieved SBP of 120 to 124 mm Hg had a hazard ratio (HR) for major cardiovascular disease of 0.71 (95% CI, 0.60-0.83) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.58 (95% CI, 0.48-0.72) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.46 (95% CI, 0.34-0.63) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.36 (95% CI, 0.26-0.51) compared with those with a mean achieved SBP of 160 mm Hg or more. Likewise, randomized groups with a mean achieved SBP of 120 to 124 mm Hg had an HR for all-cause mortality of 0.73 (95% CI, 0.58-0.93) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.59 (95% CI, 0.45-0.77) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.51 (95% CI, 0.36-0.71) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.47 (95% CI, 0.32-0.67) compared with those with a mean achieved SBP of 160 mm Hg or more. Conclusions and Relevance: This study suggests that reducing SBP to levels below currently recommended targets significantly reduces the risk of cardiovascular disease and all-cause mortality. These findings support more intensive control of SBP among adults with hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2017.1421

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Self-citation
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
(2015) · The Lancet · doi:10.1016/s0140-6736(14)61682-2 · Cited by 7,439
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755

Show all 33 references

Research works printed but not linked: 1

[17]17. Jones DW, Weatherly L, Hall JE. SPRINT: what remains unanswered and where do we go from here? Hypertension. 2016;67(2):261-262.

Sorted by citations

Items 601–700 of 783

Patterns of adherence to home blood pressure monitoring among men and women in the Electronic Framingham Heart Study
Paul, T. J., Sadaniantz, K. A., Soni, A., Asaker, J.-C., Pathiravasan, C. H., Mehawej, J., Filippaios, A., Zhang, Y., Wang, Z., Liu, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337284 · Cited by 1
“While tight blood pressure control has been shown to decrease the risk of cardiovascular events and all-cause mortality, rates of control in adults with hypertension have been inadequate [6,7].”
A randomized controlled trial on the application of a chronic disease management platform based on digital health technology combined with an innovative model of intelligent management for hypertension in patients with hypertension
Liu, K., Niu, B., Zhang, X., Zhang, L., Gao, Y., & Lu, J. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1678235 · Cited by 1
Translation, Reliability, Psychometric Validation, and Confirmatory Factor Analysis of the Urdu Version of the Self‐Efficacy for Appropriate Medication Use Scale (SEAMS‐U) Among Hypertensive Patients in Lahore, Pakistan: A Validation Study
Arshed, M., Kiran, M., Raashed, M., Umar, A., Lone, S. B., Qamer, S., Yaqoob, M., Kripalani, S. B., Zofeen, S., Iqbal, S., et al. (2026) · Health Science Reports · doi:10.1002/hsr2.72325 · Cited by 1
“Fortunately, evidence suggests that reducing systolic blood pressure can mitigate the risk of cardiovascular events and all‐ cause mortality [4].”
Minimizing Adverse Effects in Hypertension Treatment
McDermott, M. M., & Persell, S. D. (2026) · JAMA · doi:10.1001/jama.2026.7685 · Cited by 1
Prevention of Stroke
Elkind, M. S. V. (2026) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001705 · Cited by 1
Population-level mortality benefits of hypothetical blood pressure lowering interventions in middle-aged and older Chinese adults: a modelling study
Wang, M., Qian, F., Chu, X., Li, A. L., & Li, H. (2026) · QJM · doi:10.1093/qjmed/hcag200 · Cited by 1
Blood pressure goals: A moving target
Thinda, N., Tringali, S., & Huang, J. (2018) · World Journal of Hypertension · doi:10.5494/wjh.v8.i1.1 · Cited by 1
Evidence-Based Information Which Could Influence Arterial Hypertension Treatment Approach after Publication of SPRINT Trial Results
Gilyarevsky, S. R., Георгиевна, Б. Н., Golshmid, M. V., Юрьевна, З. Г., Kuzmina, I. M., & Sinitcina, I. I. (2020) · Kardiologiia · doi:10.18087/cardio.2020.8.n1177 · Cited by 1
Quantifying the influence of location of residence on blood pressure in urbanising South India: a path analysis with multiple mediators
Sørensen, T. B., Vansteelandt, S., Wilson, R., Gregson, J., Shankar, B., Kinra, S., & Dangour, A. D. (2021) · Epidemiologic Methods · doi:10.1515/em-2019-0035 · Cited by 1
Blood pressure and 10-year all-cause mortality: Findings from the PERU MIGRANT Study
Hidalgo-Benites, A., Senosain-Leon, V., Carrillo-Larco, R. M., Ruíz-Alejos, A., Gilman, R. H., Smeeth, L. L., Miranda, J. J., & Bernabé‐Ortiz, A. (2021) · F1000Research · doi:10.12688/f1000research.73900.1 · Cited by 1
Improving outcomes for older hypertensive patients: is more intensive treatment better?
Deng, Y., Liu, Y., Li, Y., Bai, J., & Cai, J. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2058491 · Cited by 1
“[75], the lowest risk of major cardiovascular events was observed where the participants had SBP achieved between 120 and 124 mmHg.”
Background
Intensive Blood Pressure Treatment Goals: Evidence for Cardiovascular Protection From Observational Studies and Clinical Trials
Whelton, P. K., Bundy, J. D., & Carey, R. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac045 · Cited by 2
Self-citation
The DASH diet - beneficial impacts on cardiovascular system and even more
Maj, D., Wieteska, M., Gorecka, A., Gorajek, A., & Wacławska, M. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.06.011 · Cited by 1
Fixed drug combinations as a way of complex antihypertensive therapy optimization: focus on the combination of amlodipine, indapamide, perindopril
Povetkin, S. V., & Александрович, К. А. (2022) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2022-28-1-17-26 · Cited by 1
Best Strategy for Perioperative Angiotensin-Converting Enzyme-Inhibitor (ACE-I) and Angiotensin II Receptor Blocker (ARB) Therapy Prior to Noncardiac Surgery
Hollmann, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77846-6.00013-6 · Cited by 1
Comparison of Blood Pressure Variability among Clinical Subtypes in Irritable Bowel Syndrome Patients with Hypertension
Kazan, E. D., Kazan, S., & Tunca, O. (2023) · Kocaeli Üniversitesi Sağlık Bilimleri Dergisi · doi:10.30934/kusbed.1190888 · Cited by 2
The correlation between different antihypertensive treatments and prognosis of cardiovascular disease in hypertensive patients
Liu, S., Li, F. Y., Zhang, C., Wei, B., Wan, J., & Shao, H. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03381-x · Cited by 1
Cardiovascular outcomes according to on-treatment systolic blood pressure in older hypertensive patients: a multicenter cohort using a common data model
Kim, J. H., Joo, H. J., Chung, S. H., Yum, Y., Kim, Y. H., & Kim, E. J. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003544 · Cited by 1
“These findings support the recommendation in ACC/AHA guideline, which suggests”
MethodResult
Effect of intelligent hypertension management system on blood pressure: protocol for a randomised controlled multicentre trial
Yu, H., Chen, X., Xia, J., & Hou, L. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074580 · Cited by 1
Pharmacotherapies for Cardiovascular Disease Prevention
Ballard‐Hernandez, J., & Irwin, C. W. (2024) · Springer eBooks · doi:10.1007/978-3-031-53705-9_14 · Cited by 1
Role of ACE Inhibitors and Angiotensin Receptor Blockers in Peripheral Artery Disease
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_8 · Cited by 1
Hypertension Self-Management Among African American Adults
Sharma, D. P., Aycock, D. M., Kelley, S. J., & Gaillard, T. R. (2025) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001172 · Cited by 1
On the practice of rapid blood pressure reduction with oral medications. A scientific view
Erlikh, A. D., Rodionov, A. V., Yavelov, I. S., Shchekochikhin, D., Кашталап, В. В., Martsevich, S. Y., & Мацкеплишвили, С. Т. (2025) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2025-4197 · Cited by 3
Long‐Term Effects of Sustained Regular Medication in Hypertensive Patients in Yunnan, China: A Cohort Study of 5 Years’ Follow‐Up
Ma, M., Wang, H., Pang, L., Guo, Z., Sun, M., Zhao, Y., Shi, Y., Wu, X., Song, J., Zhu, Q., et al. (2025) · International Journal of Hypertension · doi:10.1155/ijhy/4505824 · Cited by 1
“Other research [47, 48] shows that a reduction of SBP by 10 mmHg or DBP by 5 mmHg reduces CVD risk.”
The role of oxidative stress in modulating mortality risk across the hypertension control cascade
Liu, W., Hou, C., Wang, H., Du, H., Dai, X., Jiang, Y., & Hou, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1621911 · Cited by 1
Find and Plug the Leak: Improving Adherence to Anti-Hypertensive Medicines
Njuguna, B., & Vedanthan, R. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6753-y · Cited by 1
“Adherence to anti-hypertensive medicines is the cornerstone to blood pressure control and subsequent reductions in CVD related death and disability [3].”
Background
Blutdruckzielwerte
Hoffmann, U. (2018) · Der Internist · doi:10.1007/s00108-018-0388-3 · Cited by 1
Hypertension in Diabetic Kidney Disease
Ruiz‐Hurtado, G., & Ruilope, L. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_20 · Cited by 1
The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients
Kelley, E. F., Olson, T. P., Curry, T. B., Sprissler, R. S., & Snyder, E. M. (2019) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546819845883 · Cited by 1
Hol van a normális és a kóros vérnyomás közötti határ, és mi a terápiás cél a cardiovascularis és a renalis betegségekben?
Kékes, E., Nagy, J., & Vályi, P. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32168 · Cited by 1
Different cardiovascular responses to exercise training in hypertensive women receiving β-blockers or angiotensin receptor blockers: A pilot study
Mariano, I. M., Amaral, A. L., Carrijo, V. H. V., Costa, J. G., Rodrigues, M. D. L., Cunha, T. M., & Puga, G. M. (2022) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2022.2065290 · Cited by 1
“Moreover these reductions can avoid myocardial infarction, stroke and mortality (21).”
Background
Considerations for Optimal Blood Pressure Target of Hypertension
Ling, Q., & Cai, J. (2022) · Cardiology Discovery · doi:10.1097/cd9.0000000000000056 · Cited by 1
A New Era of Renal Denervation Trials for Patients With Hypertension?
Jalil, F., & White, W. B. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.11.009 · Cited by 1
New Guidelines, Increasing Hypertension Numbers, Resistance and Resistance to Change?
Ventura, H. O., Stewart, M. H., & Lavie, C. J. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.03.014 · Cited by 1
Intensive systolic blood pressure lowering strategy in adults with hypertension: Is lower still better?
Yousufuddin, M., Barkoudah, E., & Qayyum, R. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad054 · Cited by 1
Trends difference in prevalence of hypertension subtypes and hypertension control in US adults as defined by 2017 ACC/AHA Guideline and 2003 JNC7 GuidelinePreprint
Huang, Z., Du, X., Tang, R., Wang, W., Zhou, M., Ding, Y., Liu, N., Yang, Y., Li, X., Zhao, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3290953/v1 · Cited by 1
Blood Pressure as a Key Mediator in the Link Between Type 2 Diabetes and Heart Failure: Insights from Mendelian RandomizationPreprint
Yan, Z., Fu, S., Zhang, J., Chen, J., Guo, L., Liu, Y., Huang, P., Mao, Y., Bai, R., & Ma, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3971296/v1 · Cited by 1
Self-citation
Risk Factors of Hypertension in Low- and Middle-income Countries: A Prompt Portray
Ahmad, R., Sinha, S., Chowdhury, K., & Haque, M. (2024) · Advances in Human Biology · doi:10.4103/aihb.aihb_56_24 · Cited by 1
Beyond blood pressure target goals: treatment responsiveness as a key prognostic factor in hypertensive patients with coronary artery disease
Ogimoto, A. (2024) · Hypertension Research · doi:10.1038/s41440-024-02034-6 · Cited by 1
“In addition, two systematic reviews and meta-analyses [4, 5] showed that reducing systolic BP to levels below currently recommended targets signi ﬁ cantly reduces the risk of cardiovascular disease and all-cause mortality.”
Response by Bress et al to Letters Regarding Article, “Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey)”
Bress, A. P., Kramer, H., & Cooper, R. (2017) · Circulation · doi:10.1161/circulationaha.117.029937
Safety vs Efficacy of Lowering Blood Pressure
Gąsowski, J., Piotrowicz, K., & Grodzicki, T. K. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3537
Safety vs Efficacy of Lowering Blood Pressure—Reply
Yancy, C. W., & Bonow, R. O. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3540
Safety vs Efficacy of Lowering Blood Pressure
Bavishi, C., Bangalore, S., & Messerli, F. H. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3534
Effect of antihypertensive treatment at different blood pressure levels
Brunström, M. (2017) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Letter by Koh Regarding Article, “J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm”
Koh, K. K. (2018) · Circulation · doi:10.1161/circulationaha.117.033172
The Effect of Long-term Aerobic Exercise and Training Intensity on Blood Pressure in the Elderly
Ingeström, E. (2018) · BIBSYS Brage (BIBSYS (Norway))
Searching for an Optimal Systolic Blood Pressure Target: A Balance of Benefits and Risks
Leung, A. A. C., & Padwal, R. S. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.037
Evaluation of sST-2 Role in LVH Regression Obtained in Hypertensive Mice Models After Blocking Renin-Angiotensin System
Yusetyani, L., Rofida, S., Lestari, D., Kurniawa, W., Hijriani, N., Saputra, I. N., Soeharto, S., & Rahman, M. S. (2019) · Journal of Tropical Life Science · doi:10.11594/jtls.09.01.01
“Meta-analysis studies suggested that reducing systolic blood pressure to levels below currently guidelines recommended targets could reach to significantly reduction of the risk of cardiovascular disease and all-cause mortality [5, 6].”
Background
Prehypertension: A Case in Favor of Early Use of Diuretics
Fuchs, F. D., & Fuchs, S. C. P. C. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_40
Diabetiker kurz nach akutem Koronarsyndrom? Cave bei Blutdruck <130/80 mmHg!
Fritschka, E. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1407-0
Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare
Drapkina, O. M., Владиславович, Е. М., Gilyarevsky, S. R., & Шепель, Р. Н. (2019) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-4-578-585 · Cited by 1
A call for improved reporting on serious adverse events in clinical trials
Schutte, A. E. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002194
“[2] included 42 trials (including 144 220 patients) and showed that randomized groups with a mean achieved SBP of 120–124 mmHg had a hazard ratio for major cardiovascular disease of 0.”
Background
Cardiovascular disease risk level and health-related quality of life of patients with pulmonary tuberculosis
Antang, E. A., & Man, R. (2019) · International Journal of Advance Research in Medical Surgical Nursing · doi:10.33545/surgicalnursing.2019.v1.i1b.13
“[11] that reducing systolic blood pressure to levels below currently recommended targets significantly reduces the CVD risk and all-cause mortality.”
Background
Respostas pressóricas ao treinamento combinado em mulheres hipertensas após a menopausa sob efeito de medicamentos beta-bloqueadores ou bloqueadores de receptores de angiotensina
Mariano, I. M. (2019) · doi:10.14393/ufu.di.2019.1240
Personnalisation du rapport bénéfice/risque du traitement de l’hypertension artérielle
Porcher, R., & Blacher, J. (2020) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2020.02.013
Trends in body mass index and blood pressure associations from 1989 to 2018: co-ordinated analysis of 145,399 participantsPreprint
Bann, D., Scholes, S., Hardy, R., & O’Neill, D. (2020) · medRxiv · doi:10.1101/2020.11.06.20226951
Stroke in the Long Term. Prognosis, comorbidity, disability, readmission, and the caregiver perspective
Sennfält, S. (2020) · Lund University Publications (Lund University)
Effectiveness of virtual reality therapy upon anxiety and blood pressure among patients undergoing CABG
Sheeba, N. (2018)
Secondary prevention after acute coronary syndrome : antiplatelet therapy and risk factor control
Henriksson, R. (2020)
The great debate : does it matter how you lower blood pressure?
Rayner, B. L., & Heradien, M. J. (2020) · South African General Practitioner · doi:10.36303/sagp.2020.1.5.0047
Innovative technologies in hypertension control A telemonitored cuff-less blood pressure device
Xufre, M. T. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Systolic Blood Pressure is Positively Correlated With Headache Frequency: A 3-Month Follow-Up Study on 441 Migraine PatientsPreprint
Wang, Y.-F., Tzeng, Y., Lipton, R. B., Kuan, A. S., Chen, S., Cheng, H.-M., Chen, C., & Wang, S. (2020) · Research Square · doi:10.21203/rs.3.rs-126679/v1
“In the baseline analysis of the present study, headache frequencies were correlated with SBPs in migraine patients, consistent with some prior reports, which provided evidence in favor of a positive association between migraine and hypertension (8-10, 13-15, 27-30).”
MethodResult
Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: a review
Habeeb, B., Nassif, A., Alsuwayhiri, A., Alsharif, A., Altwairqi, K., & AlHarthi, M. S. (2021) · International Journal of Medicine in Developing Countries · doi:10.24911/ijmdc.51-1608470153
Hypertensive Cardiovascular Diseases
Li, Z.-Z., & Dang, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_1061-1
Blood pressure categories defined by the 2017 ACC/AHA guideline and all-cause mortality: a national cohort study in China and meta-analysis
Wang, J., Liu, J., Teng, H., Zhang, Y., Dong, X., Chen, W., & Yin, J. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00495-7
Prevalence, Awareness, Treatment, and Control of Hypertension in the PERSIAN Cohort Study: JNC7 Versus ACC/AHA Guidelines Short Title: The Impacts of Hypertension Definition in IranPreprint
Sepanlou, S. G., Najafi, F., Poustchi, H., Parsaeian, M., Ahmadi, A., Somi, M. H., Moradpour, F., Alizadeh‐Navaei, R., Gohari, A., Zamani, B., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-179573/v1
A precision medicine approach to lipid monitoring in the secondary prevention of cardiovascular disease
Brown, R. (2021) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.82173
Impact of 2017 ACC/AHA Guideline on Prevalence, Awareness, Treatment, Control and Risk Factors of Hypertension: a Population-based, Cross-sectional Study in IranPreprint
Sadeghi, F., Cheraghian, B., Mohammadi, Z., Sepanlou, S. G., Masoudi, S., Rahimi, Z., Danehchin, L., Paridar, Y., Abolnejadian, F., Noori, M., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-73452/v1
“Although this disease is usually asymptomatic and people are not aware of their condition, it is one of the most preventable disorder and modi cations of the lifestyle could considerably prevent the progression of CVD and renal diseases in the future.”
BackgroundInfluential
Effect of Blood Pressure on Cardiovascular Outcomes: A 15-Year Prospective Cohort StudyPreprint
Yu, Q., & Jin, Q. (2021) · Research Square · doi:10.21203/rs.3.rs-904375/v1
Hypertensive Cardiovascular Diseases
Li, Z.-Z., & Dang, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_1061
Reply
Han, M., Li, Q., Liu, L., Zhang, D., Ren, Y., Zhao, Y. K., Liu, D., Liu, F., Chen, X., Cheng, C., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002332
“Strength gains in different age groups of overweight/obese adults: A pilot uncontrolled study”
Pippi, R., Moretti, L., Carnevali, C., Tingoli, L., Settequattrini, A., Fatone, C., Perrone, C., Reginato, E., Feo, P. D., & Fanelli, C. G. (2022) · Cogent Social Sciences · doi:10.1080/23311886.2022.2106645
“…differences among groups, systolic blood pressure (SBP), a well-known risk factor for cardiovascular disease (VD) and all-cause mortality in adults (Bundy et al. 2017), changed more in the middle aged and older groups, bringing down the average SBP in these groups to levels similar to those of…”
Result
Age and gender difference in blood pressure associations with cardiovascular outcomes and diabetes: a national population-based cohort studyPreprint
yu, Q., & Jin, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1452038/v1
Vitamin D intake and stroke incidence in adults
Sulastri, I., & Putriana, D. (2022) · JHeS (Journal of Health Studies) · doi:10.31101/jhes.2471
“…of stroke can increase with increasing blood pressure and decrease if blood pressure can be maintained below 140/90 mmHg, both in ischemic stroke, intracranial hemorrhage, and subarachnoid hemorrhage (Bundy et al., 2017; Meschia et al., 2014; Wajngarten & Silva, 2019; Williamson et al., 2016).”
Background
The effect of telemonitoring and self-management mobile application on controlling blood pressure among patients with hypertension (Preprint)Preprint
Eldawati, E., Said, F. M., & Umar, N. S. (2022) · doi:10.2196/preprints.44464
Blood pressure and 10-year all-cause mortality: Findings from the PERU MIGRANT Study
Hidalgo-Benites, A., Senosain-Leon, V., Carrillo-Larco, R. M., Ruíz-Alejos, A., Gilman, R. H., Smeeth, L. L., Miranda, J. J., & Bernabé‐Ortiz, A. (2023) · F1000Research · doi:10.12688/f1000research.73900.2
Hypertension artérielle : qui traiter, jusqu’où et comment ?
Steichen, O. (2023) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2023.01.008
Health and social effectiveness of the expansion of medicine assistance programs for patients with coronary artery disease and comorbidities
Drapkina, O. M., Васильевна, К. А., Lukyanov, М. М., Кямиловна, М. Д., Александровна, А. А., & Boytsov, S. A. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3528
Hypertension and the metabolic syndrome: toward personalized management
Neeland, I. J., & Dobre, M. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00019-x
Blood pressure and 10-year all-cause mortality: Findings from the PERU MIGRANT Study
Hidalgo-Benites, A., Senosain-Leon, V., Carrillo-Larco, R. M., Ruíz-Alejos, A., Gilman, R. H., Smeeth, L. L., Miranda, J. J., & Bernabé‐Ortiz, A. (2023) · F1000Research · doi:10.12688/f1000research.73900.3
Hypertension Trends and Disparities over Twelve Years in a Large Health System: Leveraging the Electronic Health RecordsPreprint
Brush, J. E., Lu, Y., Liu, Y., Asher, J. R., Li, S., Sawano, M., Young, P., Schulz, W. L., Anderson, M., Burrows, J. S., et al. (2023) · medRxiv · doi:10.1101/2023.08.24.23294518
Long-term effects of sustained regular medication in hypertensive patients: a cohort study in ChinaPreprint
Ma, M., Wang, H., Pang, L., Guo, Z., Sun, M., Zhao, Y., Shi, Y., Wu, X., Song, J., Zhu, Q., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3284274/v1
Development and validation of a tool to assess hypertension and diabetes management in older adults within the National Essential Public Health Services Program (NEPHSP) in ChinaPreprint
Liu, L., Meicen, L. I. U., Linghe, Y. A. N. G., Chen, X. S., Liu, Y., & Lili, Y. O. U. (2023) · Research Square · doi:10.21203/rs.3.rs-3366412/v1
Mechanisms of the Effect of Abdominal Acupressure on Essential Hypertension Based on the Brain-Gut Axis
吕, 小. (2023) · Traditional Chinese Medicine · doi:10.12677/tcm.2023.1210426
A Resampling Approach for Causal Inference on Novel Two-Point Time-Series with Application to Identify Risk Factors for Type-2 Diabetes and Cardiovascular Disease
Dai, X., Mouti, S., do Vale, M. L., Ray, S., Bohn, J. R., & Goldberg, L. R. (2023) · Statistics in Biosciences · doi:10.1007/s12561-023-09390-w
Factors influencing self-quantification for patients with hypertension: A cross-sectional Study
Ma, G., Fang, H., Wang, X., Meng, Y., Zhu, Y., & Zhang, C. (2023) · Medicine · doi:10.1097/md.0000000000036185
“[1] A comprehensive systematic review, which covered studies from 90 countries, revealed that the prevalence of hypertension stands at 31.1%.”
BackgroundInfluential
Protocol for scoping review to identify current paediatric hypertension surveillance techniques in the sub-Saharan African regionPreprint
Alaofin, O. S., Gafane-Matemane, L. F., Mokwatsi, G. G., Jobe, M., & Kruger, R. (2023) · Research Square · doi:10.21203/rs.3.rs-3716785/v1
Food consumption pattern for hypertension patient in Klaten Regency, Central Java Province, Indonesia
Nasyaroeka, A. E. B. D., Solikhah, S., & Lianawati, L. (2024) · Jurnal Cakrawala Promkes · doi:10.12928/jcp.v6i1.8461
Differences in Antihypertensive Medication Prescription Profiles Between 2009 and 2021: A Retrospective Cohort Study of CARTaGENE
Ivensky, V., Zonga, P., Dallaire, G., Desbiens, L., Nadeau‐Fredette, A., Rousseau, G., & Goupil, R. (2024) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581241234729
The business case for quality: estimating lives saved and harms avoided in a value-based purchasing model
Amico, P. R., Drye, E. E., Lee, P., Lantigua, C., & Safran, D. G. (2024) · Health Affairs Scholar · doi:10.1093/haschl/qxae052
“Since lowering blood pressure reduces mortal - ity risk across a wide range of blood pressures, 16,37 health plans’ efforts to improve care incentivized by quality measures likely benefit many more patients than those we counted (eg, those newly diagnosed through better screening programs for…”
Background
Medical effectiveness and cost-effectiveness of a multidisciplinary team-based approach to the management of community residents with hypertension: an analysis of an interventional follow-up studyPreprint
Xu, Y., Du, X., Jin, Y., Wu, Y., Wu, S., Yue, J., Wang, X., Shen, H., Zhao, Y., Xia, W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4411184/v1
How do the guideline recommendations work for you? Patients’ perceived effectiveness of therapeutic approaches in arterial hypertension
Seiffert, J., Ortelbach, N., Hummel, A., O′Malley, G., Stamm, T. J., & Haller, K. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-024-00951-0
Therapeutic Strategies to Prevent First Stroke
Gkaliagkousi, Ε., Lazaridis, A. A., Spiliopoulou, S., & Manios, E. (2024) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-64928-8_11
Blood Pressure Levels Within Target
Li, M., Shantsila, E., & Lip, G. Y. H. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.09.013
Variability in Cardiometabolic Parameters and All-Cause and Cause-Specific Mortality in Older Adults: Evidence From 2 Prospective Cohorts
Lu, J., Zhou, R., Huang, J.-Q., Zhong, Q., Huang, Y., Hong, J.-R., Liu, L.-B., Li, D.-X., & Wu, X.-B. (2024) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2024.12.006
Associação entre Indicadores Antropométricos e Hipertensão Arterial em Mulheres Brasileiras Atendidas pela Estratégia de Saúde da Família
Neves, F. S., Silva, L., Campos, A. A. L., Duque, K. D. C. D., Machado, M. L. S. M., Silva, G. A. E., & Bustamante-Teixeira, M. T. (2024) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x202432040064
Acompanhamento farmacoterapêutico ao idoso em uma cidade polo do Vale do Jequitinhonha
Lage, S. L. D. S., Aquino, D. C., Teixeira, I. M. F., da Costa, J. M., & de Andrade, R. A. (2025) · Research Society and Development · doi:10.33448/rsd-v14i1.47914
High Intensity Interval Training and Arterial Hypertension: Quality of Reporting
Bünzen, C., Oberbeck, K., Ketelhut, S., & Weisser, B. (2025) · Sports Medicine International Open · doi:10.1055/a-2493-9466 · Cited by 1
The 14-year cumulative genetic high blood pressure and risk of type 2 diabetes in Korean: observational and Mendelian randomization evidence
Jeon, J., Jung, K. J., Kimm, H., Lee, J., Nam, C. M., & Jee, S. H. (2025) · Hypertension Research · doi:10.1038/s41440-025-02099-x
Evaluating the Hypertension Cascade of Care in Adults in Urban Lao PDR: Evidence From the VITERBI Cohort Study
Loss, G. J., Wallenborn, J. T., Hu, M., Ouipoulikoune, V., Probst-Hensch, N. M., Kounnavong, S., Sayasone, S., Odermatt, P., & Fink, G. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s506857 · Cited by 1

Authors: Bundy, J. D., Li, C., Stuchlik, P., Bu, X., Kelly, T. N., Mills, K. T., He, H., Chen, J., Whelton, P. K., & He, J.
Affiliations: Tulane University (US)
Corresponding author: He, Jiang
ORCID: Bundy, Joshua D.
Li, Changwei
Bu, Xiaoqing
Kelly, Tanika N.
Mills, Katherine T.
He, Hua
Chen, Jing
Whelton, Paul K.
He, Jiang
Venue: JAMA Cardiology
Publisher: American Medical Association (AMA)
Published: 2017-07-01
Volume: 2
Issue: 7
Pages: 775
ISSN: 2380-6583 (ISSN-L)
DOI: 10.1001/jamacardio.2017.1421
PMC: PMC5710614
OpenAlex: W2618382346
Cited by: 783
References: 33
Citations by year: 2026: 59 · 2025: 102 · 2024: 96 · 2023: 99 · 2022: 65 · 2021: 95 · 2020: 80 · 2019: 78 · 2018: 73 · 2017: 35
FWCI: 56.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Cardiology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (P20GM109036)
Fogarty International Center (D43TW009107)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: systolic blood pressure, blood pressure targets, hypertension, antihypertensive therapy, cardiovascular disease, all-cause mortality, blood pressure reduction, linear dose-response relationship, cardiovascular risk reduction, cardiovascular disease prevention, cardiovascular disease prevention and treatment
MeSH terms: Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Humans, Hypertension, Mortality, Patient Care Planning, Systole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks